Clustering of the Membrane Protein by Molecular Self-Assembly Downregulates the Signaling Pathway for Cancer Cell Inhibition
Source abstract
Abstract
This work reports a cyclic peptide appended self-assembled scaffold that recognizes the membrane protein EGFR and arrests the EGFR signaling through multivalent interactions by assembly-induced aggregation. When incubated with cells, the oligomers of PAD-1 first recognize the overexpressed EGFR on cancer cell membranes for arresting EGFR, which then initiates cellular uptake through endocytosis. The accumulation of PAD-1 and EGFR in the lysosome results in the formation of nanofibers, leading to the lysosomal membrane permeabilization (LMP). These processes disrupt the homeostasis of EGFR and inhibit the downstream signaling transduction of EGFR for cancer cell survival. Moreover, LMP induced the release of protein aggregates that could generate endoplasmic reticulum (ER) stress, resulting in cancer cell death selectively. In vivo studies indicate the efficient antitumor efficiency of PAD-1 in tumor-bearing mice. As a first example, this work provides an alternative strategy for controlling protein behavior for tuning cellular events in living cells.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Supramolecular Self-Assembly in Materials · Lipid Membrane Structure and Behavior · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry, Zhejiang University, Hangzhou 310058, Zhejiang Province, China
Department of Chemistry, School of Science, Westlake University; Institute of Natural Sciences, Westlake Institute for Advanced Study, No. 600 Dunyu Road, Hangzhou 310024, Zhejiang Province, China
Funding
National Natural Science Foundation of China · Natural Science Foundation of Zhejiang Province
References (53)
Show source-provided references
1. 10.1016/j.cell.2012.12.03010.1016/j.cell.2012.12.030 ↗
2. 10.1038/2956310.1038/29563 ↗
3. 10.1016/j.cell.2008.11.03210.1016/j.cell.2008.11.032 ↗
4. 10.1242/jcs.14634010.1242/jcs.146340 ↗
5. 10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-310.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3 ↗
6. 10.1016/j.cell.2013.03.01310.1016/j.cell.2013.03.013 ↗
7. 10.1038/nnano.2013.20510.1038/nnano.2013.205 ↗
8. 10.1021/jacs.2c1042810.1021/jacs.2c10428 ↗
9. 10.1002/adma.20200851810.1002/adma.202008518 ↗
10. 10.1021/acsnano.8b0079710.1021/acsnano.8b00797 ↗
11. 10.1021/jacs.8b0772710.1021/jacs.8b07727 ↗
12. 10.1002/anie.20211364910.1002/anie.202113649 ↗
13. 10.1126/science.107082110.1126/science.1070821 ↗
14. 10.1126/science.120596210.1126/science.1205962 ↗
15. 10.1039/C7CS00472A10.1039/C7CS00472A ↗
16. 10.1073/pnas.091212410710.1073/pnas.0912124107 ↗
17. 10.1021/jacs.2c1182310.1021/jacs.2c11823 ↗
18. 10.1038/nchem.48010.1038/nchem.480 ↗
19. 10.1038/nnano.2015.23810.1038/nnano.2015.238 ↗
20. 10.1073/pnas.191365511710.1073/pnas.1913655117 ↗
21. 10.1021/jacs.6b0007310.1021/jacs.6b00073 ↗
22. 10.1002/anie.20150401810.1002/anie.201504018 ↗
23. 10.1038/s41570-022-00373-x10.1038/s41570-022-00373-x ↗
24. 10.1002/anie.20171283410.1002/anie.201712834 ↗
25. 10.1016/j.biomaterials.2016.04.03910.1016/j.biomaterials.2016.04.039 ↗
26. 10.1073/pnas.130498711010.1073/pnas.1304987110 ↗
27. 10.1021/ja510156v10.1021/ja510156v ↗
28. 10.1021/jacs.6b0690310.1021/jacs.6b06903 ↗
29. 10.1073/pnas.101654610810.1073/pnas.1016546108 ↗
30. 10.1002/anie.20201512610.1002/anie.202015126 ↗
31. 10.1002/ange.20210972910.1002/ange.202109729 ↗
32. 10.1038/s41467-019-12848-510.1038/s41467-019-12848-5 ↗
33. 10.1039/C4CS00161C10.1039/C4CS00161C ↗
34. 10.1021/acs.nanolett.2c0261210.1021/acs.nanolett.2c02612 ↗
35. 10.1021/jacs.3c0446710.1021/jacs.3c04467 ↗
36. 10.1021/ja908876410.1021/ja9088764 ↗
37. 10.1126/science.108238710.1126/science.1082387 ↗
38. 10.1016/j.cell.2018.03.05610.1016/j.cell.2018.03.056 ↗
39. 10.1038/ncomms899910.1038/ncomms8999 ↗
40. 10.1021/jm201544y10.1021/jm201544y ↗
41. 10.1111/cbdd.1312510.1111/cbdd.13125 ↗
42. 10.1021/jacs.7b0714710.1021/jacs.7b07147 ↗
43. 10.1002/adma.20210470410.1002/adma.202104704 ↗
44. 10.1021/jacs.3c0446710.1021/jacs.3c04467 ↗
45. 10.3390/cancers1311274810.3390/cancers13112748 ↗
46. 10.1016/0092-8674(93)90648-A10.1016/0092-8674(93)90648-A ↗
47. 10.1038/1672910.1038/16729 ↗
48. 10.1074/jbc.275.7.482710.1074/jbc.275.7.4827 ↗
49. 10.1038/nrc380010.1038/nrc3800 ↗
50. 10.1111/febs.1359810.1111/febs.13598 ↗
51. 10.1038/s41392-019-0073-610.1038/s41392-019-0073-6 ↗
52. 10.1038/cddis.2014.54810.1038/cddis.2014.548 ↗
53. 10.1038/nmat399810.1038/nmat3998 ↗